MARA Holdings
MARA
MicroStrategy
MSTR
Tesla
TSLA
Coinbase
COIN
NVIDIA
NVDA
US Stock MarketDetailed Quotes
KROS Keros Therapeutics
- 16.100
- +0.180+1.13%
Close Jan 3 16:00 ET
- 16.100
- 0.0000.00%
Post 20:01 ET
652.17MMarket Cap-3.08P/E (TTM)
16.524High15.740Low752.55KVolume15.900Open15.920Pre Close12.10MTurnover2.13%Turnover RatioLossP/E (Static)40.51MShares73.00052wk High1.22P/B569.47MFloat Cap15.33052wk Low--Dividend TTM35.37MShs Float88.800Historical High--Div YieldTTM4.93%Amplitude15.330Historical Low16.076Avg Price1Lot Size
About Keros Therapeutics Company
Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.
Company Profile
SymbolKROS
Company NameKeros Therapeutics
Listing DateApr 8, 2020
Issue Price16.00
Founded2015
CEODr. Jasbir Seehra, PhD
MarketNASDAQ
Employees136
Fiscal Year Ends12-31
Address1050 Waltham Street,Suite 302
CityLexington
ProvinceMassachusetts
CountryUnited States of America
Zip Code02421
Phone1-617-314-6297
Websitehttp://www.kerostx.com
Company Executives
- Name
- Position
- Salary
- Dr. Jasbir Seehra, PhD
- Chief Executive Officer and Chairman of the Board
- 8.93M
- Keith Regnante
- Chief Financial Officer and Principal Accounting Officer
- 2.20M
- Christopher Rovaldi
- Chief Operating Officer and President
- 4.69M
- Dr. Yung H. Chyung, M.D.
- Chief Medical Officer
- --
- Ran Nussbaum
- Independent Director
- 390.56K
- Nima Farzan
- Independent Director
- 388.48K
- Julius Knowles
- Independent Director
- 388.48K
- Dr. Alpna Seth, PhD
- Independent Director
- 1.02M
- Jean-Jacques Bienaime
- Lead Independent Director
- --
- Dr. Carl L. Gordon, C.F.A.,PhD
- Independent Director
- 409.37K
- Tomer Kariv
- Independent Director
- 385.86K
- Dr. Mary Ann Gray,PhD
- Independent Director
- 396.98K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.